Results 101 to 110 of about 419,327 (317)

Minor introns are embedded molecular switches regulated by highly unstable U6atac snRNA

open access: yeseLife, 2013
Eukaryotes have two types of spliceosomes, comprised of either major (U1, U2, U4, U5, U6) or minor (U11, U12, U4atac, U6atac; <1%) snRNPs. The high conservation of minor introns, typically one amidst many major introns in several hundred genes ...
Ihab Younis   +8 more
doaj   +1 more source

Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant

open access: yesFrontiers in Medicine, 2020
Atypical hemolytic uremic syndrome (aHUS) is an ultra-rare disease characterized by microangiopathic hemolysis, thrombocytopenia, and renal impairment and is associated with dysregulation of the alternative complement pathway on the microvascular ...
Rossella Piras   +12 more
doaj   +1 more source

Dactolisib outperforms Rapamycin in potentiating apoptosis induced by XPO1, Bcl‐2 and Mcl‐1 blockade in preclinical glioblastoma models

open access: yesFEBS Open Bio, EarlyView.
The PAM pathway and its impact on cellular metabolism. Color‐coded key symbols represent Rapamycin (R, orange, targeting mTOR) and Dactolisib (D, green, targeting PI3K/mTOR), indicating their sites of action. Created with BioRenders.com. Glioblastoma resists therapy through interconnected survival programs.
Kai Zhao   +23 more
wiley   +1 more source

On the splicing operation

open access: yesDiscrete Applied Mathematics, 1996
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
openaire   +1 more source

DeGenRESOLVE: An offline GUI‐based automated nanopore sequencing pipeline for viruses with custom rule‐based indel and degeneracy resolution

open access: yesFEBS Open Bio, EarlyView.
DeGenRESOLVE is an offline desktop application that turns Oxford Nanopore amplicon reads into viral consensus genomes. A rule‐based step resolves or retains ambiguous positions and indels, logging evidence. Against Illumina‐derived genomes, 36/37 resolved positions agreed when the reference matched the sample.
Shoaib Saikat   +4 more
wiley   +1 more source

MOESM5 of Giant group I intron in a mitochondrial genome is removed by RNA back-splicing

open access: yes, 2019
Additional file 5: Table S2.
Sylvia Chi (6789341)   +3 more
core   +1 more source

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach   +23 more
wiley   +1 more source

Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer

open access: yeseLife, 2019
Prostate is the most frequent cancer in men. Prostate cancer progression is driven by androgen steroid hormones, and delayed by androgen deprivation therapy (ADT).
Jennifer Munkley   +22 more
doaj   +1 more source

Approaches to Link RNA Secondary Structures with Splicing Regulation

open access: yes, 2014
In higher eukaryotes, alternative splicing is usually regulated by protein factors, which bind to the pre-mRNA and affect the recognition of splicing signals.
Mireya Plass   +3 more
core   +1 more source

Cognitive and Neuroimaging Divergence Between Juvenile and Adult FUS Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by progressive motor neuron degeneration. Fused in sarcoma (FUS)‐associated juvenile ALS (jALS) represents a distinct and aggressive subgroup with rapid deterioration and poor prognosis.
Alexandra V. Jürs   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy